10x Genomics Inc (TXG) Shares Fall 5.1% -- GF Value Says Still Overvalued

gurufocus.com · 2026-08-29

On August 28, 2026, 10x Genomics Inc (TXG) shares fell 5.1% to a current price of $61.55. The stock has experienced significant volatility, trading between $11.

TickrTrends take: TXG shares declined recently, and the company remains classified as overvalued according to GF Value metrics, which aligns with TickrTrends' current stance of awaiting full valuation assessment. For investors focused on valuation dynamics, the ongoing gap between market price and intrinsic value estimates represents a key metric to monitor as the company operates within the competitive Healthcare sector. Movement in this valuation gap could provide important signals about when a more definitive verdict becomes appropriate for the stock.

Read the full story at gurufocus.com →